Medprin Regenerative Medical Technologies Co (SZSE:301033) Gross-Profit-to-Asset % : 29.39% (As of Mar. 2025)

Medprin Regenerative Medical Technologies Co Gross-Profit-to-Asset % Chart

Medprin Regenerative Medical Technologies Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															23.77	26.74	29.22	37.07	29.39

Competitive Comparison of Medprin Regenerative Medical Technologies Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Medprin Regenerative Medical Technologies Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medprin Regenerative Medical Technologies Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medprin Regenerative Medical Technologies Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Medprin Regenerative Medical Technologies Co's Gross-Profit-to-Asset % falls into.

Medprin Regenerative Medical Technologies Co Gross-Profit-to-Asset % Calculation

Medprin Regenerative Medical Technologies Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Medprin Regenerative Medical Technologies Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Medprin Regenerative Medical Technologies Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Medprin Regenerative Medical Technologies Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medprin Regenerative Medical Technologies Co Business Description